SESSION I: FIXED VS CONTINUOUS TREATMENTS IN HIGH-RISK PATIENTS

SESSION II: NEW SCENARIOS IN CLL

Evolving therapeutic strategies in R/R CLL
M. Coscia (Varese) - NON AUTORIZZATA
Keynote Lecture

Current and emerging therapies in Mantle Cell Lymphoma
A. Pinto (Napoli) - NON AUTORIZZATA
SESSION IV: NEW PERSPECTIVES IN R/R DLBCL

Emerging drugs in R/R DLBCL
M. Martelli (Roma)
CAR-T cell therapy: what is the best timing?
M. Martino (Reggio Calabria)
SESSION V: CONTROVERSIES IN R/R FL

CAR-T cell before new drugs: No
M. Gentile (Cosenza)
CAR-T cell before new drugs: Yes
F. Frigeri (Caserta)
SESSION VI: LYMPHOMAS QUESTIONS and ANSWERS